Researchers in this study wanted to determine whether signs of inflammation in non-cancerous breast tissue could help predict future breast cancer risk in African American women. While benign breast disease is known to increase the risk of developing breast cancer, researchers wanted to identify biological markers within breast tissue that could provide additional information about a woman's likelihood of developing invasive breast cancer.
To investigate this, the researchers analyzed benign breast biopsy samples from African American women. They examined tissue for markers of inflammation, including crown-like structures of the breast (CLS-B) and infiltrating lymphocytes, which are immune cells found within breast tissue. They then compared these findings between women who later developed invasive breast cancer and those who did not.
The researchers found that women whose benign breast tissue contained signs of inflammation were more likely to develop invasive breast cancer in the future. Specifically, the presence of crown-like structures and increased immune cell infiltration were associated with a higher risk of cancer. These relationships remained significant even after accounting for other known risk factors.
Overall, the findings suggest that inflammation within benign breast tissue may play an important role in breast cancer development and could potentially serve as an early marker of risk.
